30 Jul 2019 The tender offer for all of the outstanding shares of Array expired at 6:01 p.m., Eastern Time, on July 29, 2019. Computershare Trust Company, 17 Jun 2019 Stocks making the biggest moves premarket: Pfizer, Array Biopharma, Alibaba – Alibaba is proposing an eight-for-one stock split, in a move 17 May 2019 For example, the Array BioPharma Inc. (NASDAQ:ARRY) share price The chart below shows how revenue and earnings have changed the market weighted average returns of stocks that currently trade on US exchanges. 30 Jul 2019 Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here. 8 Jul 2019 Pfizer stock has risen 2.7% since just before the acquisition was announced; shares of the S&P 500 are up 3.6% over the same period. What's ARRY Array Biopharma Inc Chart ARRY financial data 30 Jul 19, Ron Squarer, Common Stock, Sale back to company, Dispose D, 0, 442,190, 0, 0.
The Price History page allows you to view end-of-day price history (up to two years prior to today's date), view the latest trades, view corporate actions (U.S. equities only.) Barchart Premier Members may also download additional data using the "Historical Data" page, where you can download Intraday, Daily, Weekly, Monthly, or Quarterly data.
(NASDAQ: ARRY) is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat Profile for Array BioPharma Inc. (ARRY). « Back to company index. ARRY Chatter Timeline. Stock Ticker for ARRY 17 Jun 2019 Stocks to watch: Lufthansa, BAT, Hammerson, Array BioPharma. US nicotine regulation could halve industry profits, says Morgan Stanley. ARRY - Array Biopharma Stock Price History - Barchart.com
Get today's Array BioPharma Inc stock price and latest ARRY news as well as Array BioPharma real-time stock quotes, technical analysis, full financials and
Split History. Stock splits are used by Array BioPharma, Inc. to keep share prices within reasonable numbers to encourage investment. If the share price of a security gets too high, a company can perform a stock split by issuing all shareholders an extra share, thereby halving the price of an individual share.
The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Lefkoff Kyle since year 2005. The trader's CIK number is 1191818.At the time of the last reporting, Lefkoff Kyle was the Director of Array Biopharma Inc .
Array Biopharma Stock Chart - ARRY - Investors Hub
Jun 17, 2019 · Array BioPharma news for Monday concerning a deal with Pfizer (PFE) that will have the two companies coming together has ARRY stock soaring.
ARRY Stock Rating and Data | Array BioPharma - GuruFocus.com ARRY stock rating and analysis - Array BioPharma : a summary of key financial strength and profitability metrics. Array Biopharma | high stock price, low value: 2/100 Aug 02, 2019 · Last update of Combined Rank: 2-Aug-2019. Financial reporting date used for calculating ranks: 31-Mar-2019. Stock research history is based on the Obermatt Method.The higher the rank, the better Array Biopharma is in the corresponding investment strategy.. Value Metrics in Detail Array BioPharma Inc. (ARRY) Split History | Seeking Alpha See Array BioPharma Inc. (ARRY) history of stock splits. Includes date and ratio.
Array BioPharma (ARRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. Array Biopharma Share Price. 0HI0 - Stock Quote, Charts ... Array Biopharma Inc Array Biopharma Ord Shs is listed on the London Stock Exchange, trading with ticker code 0HI0. It has a market capitalisation of $10,654m, with approximately 223m shares in issue. Array Biopharma Inc Share Price History - Historical Data ... Array Biopharma price history. Array BioPharma Inc - ARRY - Stock forecast - 3 months ... ARRY stock forecast Our latest prediction for Array BioPharma, Inc.'s stock price was made on the Feb. 7, 2019 when the stock price was at 21.56$.. In the short term (2weeks), ARRY's stock price should outperform the market by 0.52%.During that period the price should oscillate between -7.29% and +8.24%.. In the medium term (3months), ARRY's stock price should outperform the market by 4.18%.